[1]左 坤,郑煜坤,陈 德,等.子宫动脉栓塞术治疗子宫动静脉畸形伴晚期产后出血16例[J].介入放射学杂志,2019,28(10):978-981.
 ZUO Kun,ZHENG Yukun,CHEN De,et al.Uterine arterial embolization for the treatment of uterine arteriovenous malformation with late postpartum hemorrhage: clinical analysis of 16 patients[J].journal interventional radiology,2019,28(10):978-981.
点击复制

子宫动脉栓塞术治疗子宫动静脉畸形伴晚期产后出血16例()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
28
期数:
2019年10期
页码:
978-981
栏目:
实验研究
出版日期:
2019-10-25

文章信息/Info

Title:
Uterine arterial embolization for the treatment of uterine arteriovenous malformation with late postpartum hemorrhage: clinical analysis of 16 patients
作者:
左 坤 郑煜坤 陈 德 康亚辉 赵有红 刘晓丽
Author(s):
ZUO Kun ZHENG YukunCHEN De KANG Yahui ZHAO Youhong LIU Xiaoli.
Gansu Provincial Maternal and Child Health Hospital, Lanzhou, Gansu Province 730050, China
关键词:
【关键词】 晚期产后出血 子宫动静脉畸形 盆腔血管栓塞 子宫切除
文献标志码:
A
摘要:
【摘要】 目的 探讨子宫动静脉畸形(AVM)伴晚期产后出血(LPH)的临床特点及治疗方式。方法回顾性收集2012年3月至2017年3月甘肃省妇幼保健院采用子宫动脉栓塞术(UAE)治疗的16例子宫AVM伴LPH患者临床资料,分析其临床特点、治疗效果和预后。结果 16例患者妊娠次数1~6次,平均 (2.3±1.25)次, 其中首次妊娠1例,2~4 次13例,≥5次2例。本次妊娠引产和自然分娩12例,剖宫分娩4例。16例中10例有宫腔操作史,其中≥2次者4例;LPH发病时间为产后5~43 d,其中突发阴道大量流血6例,并发失血性休克2例;出血量>1 000 mL7例,间歇性子宫出血9例;均有不同程度贫血,需输血4例。盆腔动脉DSA造影显示双侧子宫动脉瘘3例,单侧子宫动脉瘘11例,子宫动脉假性动脉瘤2例。16例患者均接受UAE,术后予宫腔镜下病灶电切术5例,清宫术2例,子宫切口二次修补术1例,子宫切除术2例。所有患者预后良好。 结论 子宫AVM可能是LPH发病因素之一。胎盘植入、手术创伤、子宫切口愈合不良和感染等均可引起子宫AVM发生,从而导致LPH。UAE是治疗子宫AVM伴LPH有效方法。产后积极处理残留胎盘组织,评估切口愈合状况并予干预,可降低再出血风险,避免子宫切除等不良事件发生。

参考文献/References:

[1] Dossou M, Debost- Legrand A, Dechelotte P, et al. Severe secondary postpartum hemorrhage: a historical cohort[J]. Birth,2015, 42: 149- 155.
[2] Sugarbaker P, Ihemelandu C, Bijelic L. Cytoreductive surgery and HIPEC as a treatment option for laparoscopic resection of uterine leiomyosarcoma with morcellation: early results[J]. Ann Surg Oncol, 2016, 23: 1501- 1507.
[3] 王新婧, 吕维富, 李 兵, 等. 子宫动脉栓塞治疗子宫腺肌病效果及影响因素[J]. 介入放射学杂志, 2018, 27: 619- 622.
[4] 徐新建, 吴 娟, 朱 芮, 等. 子宫动脉假性动脉瘤经导管栓塞治疗2例[J]. 介入放射学杂志, 2016, 25: 877- 879.
[5] Timor- Tritsch IE, Khatib N, Monteagudo A, et al. Cesarean scar pregnancies: experience of 60 cases[J]. J Ultrasound Med, 2015, 34: 601- 610.
[6] Roach MK, Thomassee MS. Acquired uterine arteriovenous malformation and retained placenta increta[J]. Obstet Gynecol, 2015, 126: 642- 644.
[7] Hoffmall MK, Meilstmp JW, Shackelford DP, et al. Arteriovenous malformations of the uterus: an uncommon cause of vaginal bleeding[J]. Obstet Gynecol Surv, 1997, 52: 736- 740.
[8] Timor- Tritsch IE, Haynes MC, Monteagudo A, et al. Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity/arteriovenous malformations[J]. Am J Obstet Gynecol, 2016, 214: 731.e1- 731.e10.
[9] Touhami O, Gregoire J, Noel P, et al. Uterine arteriovenous malformations following gestational trophoblastic neoplasia: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 181: 54- 59.
[10] Ore MR, Lynch D, Rumsey C. Uterine arteriovenous malformation, images, and management[J]. Mil Med, 2015, 180: e177- e180.
[11] Patton EW, Moy I, Milad MP, et al. Fertility- preserving management of a uterine arteriovenous malformation: a case report of uterine artery embolization(UAE) followed by laparoscopic resection[J]. Minim Invasive Gynecol, 2015, 22: 137- 141.
[12] Vilos AG, Vilos GA, Vrijer BD, et al. Fertility and pregnancy outcomes following uterine artery embolization(UAE) for uterine arteriovenous malformation(AVM)[J]. Gynecol Surg, 2010, 7: 401- 405.

备注/Memo

备注/Memo:
(收稿日期:2018- 11- 08)
(本文编辑:边 佶)
更新日期/Last Update: 2019-10-17